Comprehensive Bone Marrow Failure Center, Children’s Hospital of Philadelphia, Philadelphia, United States; Perelman School of Medicine, University of Pennsylvania, Philadelphia, United States
Sarah E Adams
Comprehensive Bone Marrow Failure Center, Children’s Hospital of Philadelphia, Philadelphia, United States; Perelman School of Medicine, University of Pennsylvania, Philadelphia, United States
Haotian Zheng
Department of Biostatistics, Epidemiology and Informatics, University of Pennsylvania, Philadelphia, United States
Juliana Ehnot
Comprehensive Bone Marrow Failure Center, Children’s Hospital of Philadelphia, Philadelphia, United States; Perelman School of Medicine, University of Pennsylvania, Philadelphia, United States
Seul K Jung
Comprehensive Bone Marrow Failure Center, Children’s Hospital of Philadelphia, Philadelphia, United States; Perelman School of Medicine, University of Pennsylvania, Philadelphia, United States
Greer Jeffrey
Comprehensive Bone Marrow Failure Center, Children’s Hospital of Philadelphia, Philadelphia, United States; Perelman School of Medicine, University of Pennsylvania, Philadelphia, United States
Theresa Menna
Comprehensive Bone Marrow Failure Center, Children’s Hospital of Philadelphia, Philadelphia, United States; Perelman School of Medicine, University of Pennsylvania, Philadelphia, United States
Louise Purton
Stem Cell Regulation Unit, St. Vincent's Institute of Medical Research, Fitzroy, Australia; Department of Medicine, The University of Melbourne, Parkville, Australia
Hongzhe Lee
Department of Biostatistics, Epidemiology and Informatics, University of Pennsylvania, Philadelphia, United States
Comprehensive Bone Marrow Failure Center, Children’s Hospital of Philadelphia, Philadelphia, United States; Perelman School of Medicine, University of Pennsylvania, Philadelphia, United States
Hematopoietic dysfunction has been associated with a reduction in the number of active precursors. However, precursor quantification at homeostasis and under diseased conditions is constrained by the scarcity of available methods. To address this issue, we optimized a method for quantifying a wide range of hematopoietic precursors. Assuming the random induction of a stable label in precursors following a binomial distribution, estimates depend on the inverse correlation between precursor numbers and the variance of precursor labeling among independent samples. Experimentally validated to cover the full dynamic range of hematopoietic precursors in mice (1–105), we utilized this approach to demonstrate that thousands of precursors, which emerge after modest expansion during fetal-to-adult transition, contribute to native and perturbed hematopoiesis. We further estimated the number of precursors in a mouse model of Fanconi Anemia, showcasing how repopulation deficits can be classified as autologous (cell proliferation) and non-autologous (lack of precursor). Our results support an accessible and reliable approach for precursor quantification, emphasizing the contemporary perspective that native hematopoiesis is highly polyclonal.